Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03817021 · ClinicalTrials.gov registry record · NA
ONE PATH: Optimizing Nutrition Education for Parents and Teachers for Healthy Growth
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 1,461
- Enrollment target
NCT03817021: Completed NA study, sponsored by Penn State University.
NCT03817021 is a NA study that has completed, run by Penn State University. The registered enrollment target is 1,461 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03817021, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,461 participants
- Enrollment target
Study Summary
This proposal uses an innovative methodological framework, the multiphase optimization strategy (MOST), to design an effective and efficient responsive feeding (RF) intervention that promotes child appetite self-regulation among a high-risk sample: families with preschoolers living in rural poverty. The principles of MOST emphasize efficiency, allowing identification of the most efficacious intervention components (i.e., components that contribute to treatment effects) while minimizing participant burden and cost. ONE PATH will intervene on \~768 dyads recruited from 56 classrooms serving largely low-income, rural populations.
Primary Outcome
Difference in mean COMPX score at post-intervention between intervention and control conditions: Child appetite regulation skills will be assessed using the gold standard caloric compensation score (COMPX). On 2 occasions, children will be served a smoothie \~20 minutes prior to lunch - on 1 occasion, they will receive a low-calorie smoothie, and on the other a high-calorie smoothie (order will be randomized by classroom). Children will then be served an ad-libitum lunch (same foods on both occ
Interventions
- BEHAVIORAL ECE Provider
- BEHAVIORAL Parent Intervention
- BEHAVIORAL Child intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,461 participants |
| Start Date | 2022-07-21 |
| Est. Completion | 2025-07-07 |
| Phase | NA |
What the finished NCT03817021 record still lists
NCT03817021 is an interventional study that assigns participants to a tested intervention. Its 1,461 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which ECE Provider is the first listed.
NCT03817021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03817021 about?
NCT03817021 is a clinical study titled "ONE PATH: Optimizing Nutrition Education for Parents and Teachers for Healthy Growth". This proposal uses an innovative methodological framework, the multiphase optimization strategy (MOST), to design an effective and efficient responsive feeding (RF) intervention that promotes child appetite self-regulation among a high-risk sample: families with preschoolers living in rural poverty....
What is the current status of trial NCT03817021?
This trial is currently completed. It is a NA study. The enrollment target is 1,461 participants. The study started on 2022-07-21. Estimated completion is 2025-07-07.
What interventions are being tested in trial NCT03817021?
The interventions under investigation include: ECE Provider (BEHAVIORAL), Parent Intervention (BEHAVIORAL), Child intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03817021?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03817021's enrollment target sits among peer trials
1,461 68th of 2000 higher than 1,933 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936361 · 1,456 participants · Phase 3
Statins In Intracerbral Hemorrhage
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI